{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T20:56:20Z","timestamp":1771102580829,"version":"3.50.1"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007059","name":"Northwestern University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007059","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["848002 \\u2013 AND-PD"],"award-info":[{"award-number":["848002 \\u2013 AND-PD"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.pharmthera.2024.108683","type":"journal-article","created":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T15:30:24Z","timestamp":1719675024000},"page":"108683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Ion channel dysregulation and cellular adaptations to alpha-synuclein in stressful pacemakers of the parkinsonian brainstem"],"prefix":"10.1016","volume":"260","author":[{"given":"Wei-Hua","family":"Chiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Wattad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua A.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.pharmthera.2024.108683_bb0005","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","article-title":"The functional anatomy of basal ganglia disorders","volume":"12","author":"Albin","year":"1989","journal-title":"Trends in Neurosciences"},{"issue":"3","key":"10.1016\/j.pharmthera.2024.108683_bb0010","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.neuron.2018.01.006","article-title":"Dopamine\u2019s effects on Corticostriatal synapses during reward-based behaviors","volume":"97","author":"Bamford","year":"2018","journal-title":"Neuron"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2024.108683_bb0015","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pain.2008.12.004","article-title":"Pain in Parkinson\u2019s disease: Prevalence and characteristics","volume":"141","author":"Beiske","year":"2009","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108683_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-12834-x","article-title":"Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson\u2019s disease","volume":"10","author":"Benkert","year":"2019","journal-title":"Nature Communications"},{"issue":"6","key":"10.1016\/j.pharmthera.2024.108683_bb0025","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41582-021-00486-9","article-title":"Prodromal Parkinson disease subtypes \u2014 Key to understanding heterogeneity","volume":"17","author":"Berg","year":"2021","journal-title":"Nature Reviews Neurology"},{"issue":"6","key":"10.1016\/j.pharmthera.2024.108683_bb0030","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/acn3.412","article-title":"A novel design of a phase III trial of isradipine in early Parkinson disease (STEADY-PD III)","volume":"4","author":"Biglan","year":"2017","journal-title":"Annals of Clinical and Translational Neurology"},{"issue":"10291","key":"10.1016\/j.pharmthera.2024.108683_bb0035","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.pharmthera.2024.108683_bb0040","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1093\/brain\/awm056","article-title":"Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease","author":"Boeve","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2024.108683_bb0045","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.90278.4","article-title":"Serotonergic and dopaminergic neurons in the dorsal raphe are differentially altered in a mouse model for parkinsonism","volume":"12","author":"Boi","year":"2024","journal-title":"ELife"},{"issue":"2","key":"10.1016\/j.pharmthera.2024.108683_bb0050","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3233\/JPD-202481","article-title":"The \u03b1-Synuclein origin and connectome model (SOC model) of Parkinson\u2019s disease: Explaining motor asymmetry, non-motor phenotypes, and cognitive decline","volume":"11","author":"Borghammer","year":"2021","journal-title":"Journal of Parkinson\u2019s Disease"},{"issue":"12","key":"10.1016\/j.pharmthera.2024.108683_bb0055","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/mds.21065","article-title":"Stanley Fahn lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson\u2019s disease reconsidered","volume":"21","author":"Braak","year":"2006","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"2","key":"10.1016\/j.pharmthera.2024.108683_bb0060","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2024.108683_bb0065","doi-asserted-by":"crossref","first-page":"4 56","DOI":"10.1152\/ajpcell.00139.2004","article-title":"Calcium, ATP, and ROS: A mitochondrial love-hate triangle","volume":"287","author":"Brookes","year":"2004","journal-title":"American Journal of Physiology - Cell Physiology"},{"issue":"7148","key":"10.1016\/j.pharmthera.2024.108683_bb0070","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/nature05865","article-title":"\u201cRejuvenation\u201d protects neurons in mouse models of Parkinson\u2019s disease","volume":"447","author":"Chan","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2024.108683_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"\u03b1-Synuclein locus duplication as a cause of familial Parkinson\u2019s disease","author":"Chartier-Harlin","year":"2004","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.pharmthera.2024.108683_bb0080","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson\u2019s disease: Diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.pharmthera.2024.108683_bb0085","series-title":"Comparing tonic and phasic dendritic calcium in cholinergic pedunculopontine neurons and dopaminergic substantia nigra neurons","author":"Chen","year":"2024"},{"issue":"11","key":"10.1016\/j.pharmthera.2024.108683_bb0090","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd3994","article-title":"\u03b1-Synuclein\u2013induced Kv4 channelopathy in mouse vagal motoneurons drives nonmotor parkinsonian symptoms","volume":"7","author":"Chiu","year":"2021","journal-title":"Science Advances"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108683_bb0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1113\/jphysiol.1971.sp009366","article-title":"Prediction of repetitive firing behaviour from voltage clamp data on an isolated neurone soma","volume":"213","author":"Connor","year":"1971","journal-title":"The Journal of Physiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2024.108683_bb0100","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1152\/jn.00432.2014","article-title":"Functional segregation of voltage-activated calcium channels in motoneurons of the dorsal motor nucleus of the vagus","volume":"114","author":"Cooper","year":"2015","journal-title":"Journal of Neurophysiology"},{"issue":"8","key":"10.1016\/j.pharmthera.2024.108683_bb0105","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","article-title":"The substantia nigra of the human brain: II. Patterns of loss of dopamine-containing neurons in Parkinson\u2019s disease","volume":"122","author":"Damier","year":"1999","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.pharmthera.2024.108683_bb0110","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s disease: Mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.pharmthera.2024.108683_bb0115","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0166-2236(90)90110-V","article-title":"Primate models of movement disorders of basal ganglia origin","volume":"13","author":"DeLong","year":"1990","journal-title":"Trends in Neurosciences"},{"issue":"4","key":"10.1016\/j.pharmthera.2024.108683_bb0120","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00401-008-0345-7","article-title":"Evidence that incidental Lewy body disease is pre-symptomatic Parkinson\u2019s disease","volume":"115","author":"Dickson","year":"2008","journal-title":"Acta Neuropathologica"},{"issue":"10","key":"10.1016\/j.pharmthera.2024.108683_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/mds.25952","article-title":"Stage-dependent nigral neuronal loss in incidental Lewy body and parkinson\u2019s disease","volume":"29","author":"Dijkstra","year":"2014","journal-title":"Movement Disorders"},{"issue":"24","key":"10.1016\/j.pharmthera.2024.108683_bb0130","doi-asserted-by":"crossref","first-page":"10154","DOI":"10.1523\/JNEUROSCI.5311-12.2013","article-title":"Calcium entry and alpha-synuclein inclusions elevate dendritic mitochondrial oxidant stress in dopaminergic neurons","volume":"33","author":"Dryanovski","year":"2013","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2024.108683_bb0135","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/brain\/86.4.781","article-title":"The pathology of certain medullary nuclei in parkinsonism","volume":"86","author":"Eadie","year":"1963","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2024.108683_bb0140","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1093\/brain\/awz111","article-title":"Evolution of prodromal Parkinson\u2019s disease and dementia with Lewy bodies: A prospective study","volume":"142","author":"Fereshtehnejad","year":"2019","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.pharmthera.2024.108683_bb0145","first-page":"103","article-title":"Impaired baroreflex function in mice overexpressing alpha-synuclein","volume":"23","author":"Fleming","year":"2013","journal-title":"Frontiers in Neurology"},{"issue":"4","key":"10.1016\/j.pharmthera.2024.108683_bb0150","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1152\/jn.00038.2009","article-title":"Endogenous calcium buffering capacity of substantia nigral dopamine neurons","volume":"102","author":"Foehring","year":"2009","journal-title":"Journal of Neurophysiology"},{"issue":"15","key":"10.1016\/j.pharmthera.2024.108683_bb0155","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1002\/mds.23394","article-title":"What are the most important nonmotor symptoms in patients with Parkinson\u2019s disease and are we missing them?","volume":"25","author":"Gallagher","year":"2010","journal-title":"Movement Disorders"},{"key":"10.1016\/j.pharmthera.2024.108683_bb0160","article-title":"\u03b1-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson\u2019s disease","author":"Geibl","year":"2023","journal-title":"BioRxiv: The Preprint Server for Biology"},{"issue":"4986","key":"10.1016\/j.pharmthera.2024.108683_bb0165","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.2147780","article-title":"D 1 and D 2 dopamine receptor-regulated gene expression of Striatonigral and Striatopallidal neurons","volume":"250","author":"Gerfen","year":"1990","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108683_bb0170","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","article-title":"100 years of Lewy pathology","volume":"9","author":"Goedert","year":"2013","journal-title":"Nature Reviews Neurology"},{"issue":"10","key":"10.1016\/j.pharmthera.2024.108683_bb0175","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/nn.3209","article-title":"Calcium entry induces mitochondrial oxidant stress in vagal neurons at risk in Parkinson\u2019s disease","volume":"15","author":"Goldberg","year":"2012","journal-title":"Nature Neuroscience"},{"issue":"7886","key":"10.1016\/j.pharmthera.2024.108683_bb0180","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/s41586-021-04059-0","article-title":"Disruption of mitochondrial complex I induces progressive parkinsonism","volume":"599","author":"Gonz\u00e1lez-Rodr\u00edguez","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2024.108683_bb0185","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.autneu.2016.06.003","article-title":"Cardiac vagal preganglionic neurones: An update","volume":"199","author":"Gourine","year":"2016","journal-title":"Autonomic Neuroscience: Basic & Clinical"},{"issue":"3","key":"10.1016\/j.pharmthera.2024.108683_bb0190","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.neurobiolaging.2012.07.008","article-title":"Dietary energy intake modifies brainstem autonomic dysfunction caused by mutant \u03b1-Synuclein","volume":"34","author":"Griffioen","year":"2013","journal-title":"Neurobiology of Aging"},{"issue":"6","key":"10.1016\/j.pharmthera.2024.108683_bb0195","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1172\/JCI95898","article-title":"Systemic isradipine treatment diminishes calcium-dependent mitochondrial oxidant stress","volume":"128","author":"Guzman","year":"2018","journal-title":"The Journal of Clinical Investigation"},{"issue":"7324","key":"10.1016\/j.pharmthera.2024.108683_bb0200","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nature09536","article-title":"Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1","volume":"468","author":"Guzman","year":"2010","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.pharmthera.2024.108683_bb0205","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/mds.27802","article-title":"Update of the MDS research criteria for prodromal Parkinson\u2019s disease","volume":"34","author":"Heinzel","year":"2019","journal-title":"Movement Disorders"},{"issue":"46","key":"10.1016\/j.pharmthera.2024.108683_bb0210","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc2487","article-title":"Determinants of seeding and spreading of \u03b1-synuclein pathology in the brain","volume":"6","author":"Henrich","year":"2020","journal-title":"Science Advances"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108683_bb0215","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40478-018-0541-1","article-title":"A53T-\u03b1-synuclein overexpression in murine locus coeruleus induces Parkinson\u2019s disease-like pathology in neurons and glia","volume":"6","author":"Henrich","year":"2018","journal-title":"Acta Neuropathologica Communications"},{"issue":"2","key":"10.1016\/j.pharmthera.2024.108683_bb0220","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0002-9440(10)64553-1","article-title":"Alpha-synuclein promotes mitochondrial deficit and oxidative stress","volume":"157","author":"Hsu","year":"2000","journal-title":"The American Journal of Pathology"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108683_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-88374-6","article-title":"Whole-brain mapping of monosynaptic inputs to midbrain cholinergic neurons","volume":"11","author":"Huerta-Ocampo","year":"2021","journal-title":"Scientific Reports"},{"issue":"42","key":"10.1016\/j.pharmthera.2024.108683_bb0230","first-page":"E4016","article-title":"Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model","volume":"110","author":"Janezic","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"Pt3","key":"10.1016\/j.pharmthera.2024.108683_bb0235","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1469-7793.1998.869bs.x","article-title":"Activity of C fibre cardiac vagal efferents in anaesthetized cats and rats","volume":"507","author":"Jones","year":"1998","journal-title":"Journal of Physiology"},{"issue":"21","key":"10.1016\/j.pharmthera.2024.108683_bb0240","doi-asserted-by":"crossref","first-page":"7401","DOI":"10.1523\/JNEUROSCI.0143-10.2010","article-title":"Pacemaking in dopaminergic ventral tegmental area neurons: Depolarizing drive from background and voltage-dependent sodium conductances","volume":"30","author":"Khaliq","year":"2010","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"issue":"7306","key":"10.1016\/j.pharmthera.2024.108683_bb0245","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nature09159","article-title":"Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry","volume":"466","author":"Kravitz","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2024.108683_bb0250","series-title":"Calcium channel blocker use and risk of Parkinson\u2019s disease: a meta-analysis","author":"Lang","year":"2015"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108683_bb0255","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1523\/JNEUROSCI.1079-16.2016","article-title":"Mutant \u03b1 -synuclein overexpression induces stressless pacemaking in vagal motoneurons at risk in parkinson\u2019s disease","volume":"37","author":"Lasser-Katz","year":"2017","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2024.108683_bb0260","doi-asserted-by":"crossref","DOI":"10.1177\/17562864241252713","article-title":"Calcium channel blockers and Parkinson\u2019s disease: A systematic review and meta-analysis","volume":"17","author":"Lin","year":"2024","journal-title":"Therapeutic Advances in Neurological Disorders"},{"issue":"20","key":"10.1016\/j.pharmthera.2024.108683_bb0265","doi-asserted-by":"crossref","first-page":"5715","DOI":"10.1093\/emboj\/20.20.5715","article-title":"Tuning pacemaker frequency of individual dopaminergic neurons by Kv4.3L and KChip3.1 transcription","volume":"20","author":"Liss","year":"2001","journal-title":"The EMBO Journal"},{"issue":"6109","key":"10.1016\/j.pharmthera.2024.108683_bb0270","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.pharmthera.2024.108683_bb0275","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3233\/JPD-150685","article-title":"The concept of prodromal Parkinson\u2019s disease","volume":"5","author":"Mahlknecht","year":"2015","journal-title":"Journal of Parkinson\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2024.108683_bb0280","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1038\/s41598-022-06832-1","article-title":"Enhanced firing of locus coeruleus neurons and SK channel dysfunction are conserved in distinct models of prodromal Parkinson\u2019s disease","volume":"12","author":"Matschke","year":"2022","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108683_bb0285","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1113\/jphysiol.1976.sp011414","article-title":"The location of cardiac vagal preganglionic motoneurones in the medulla of the cat","volume":"258","author":"McAllen","year":"1976","journal-title":"The Journal of Physiology"},{"issue":"7","key":"10.1016\/j.pharmthera.2024.108683_bb0290","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00702-016-1530-9","article-title":"Structural and functional considerations of the cholinergic brainstem","volume":"123","author":"Mena-Segovia","year":"2016","journal-title":"Journal of Neural Transmission (Vienna, Austria: 1996)"},{"key":"10.1016\/j.pharmthera.2024.108683_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2017.02.027","article-title":"Rethinking the Pedunculopontine nucleus: From cellular organization to function","volume":"94","author":"Mena-Segovia","year":"2017","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108683_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-022-01842-z","article-title":"Human \u03b1-synuclein overexpression in mouse serotonin neurons triggers a depressive-like phenotype. Rescue by oligonucleotide therapy","volume":"12","author":"Miquel-Rio","year":"2022","journal-title":"Translational Psychiatry"},{"key":"10.1016\/j.pharmthera.2024.108683_bb0305","doi-asserted-by":"crossref","unstructured":"Moratalla, R., Sanz-Magro, A., Granado, N., Garc\u00eda-Verdugo, M., Salas, C., Alberquilla, S., \u2026 Jercog, P. (2023). Dysfunctional dorsal raphe dopaminergic neurons and locus coeruleus noradrenergic neurons cause anxiety and depression in a Parkinson's disease mouse model. Doi: 10.21203\/RS.3.RS-3407836\/V1.","DOI":"10.21203\/rs.3.rs-3407836\/v1"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108683_bb0310","doi-asserted-by":"crossref","first-page":"R92","DOI":"10.1152\/ajpregu.1982.243.1.R92","article-title":"Vagal cardiac preganglionic neurons: Distribution, cell types, and reflex discharges","volume":"243","author":"Nosaka","year":"1982","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"issue":"9","key":"10.1016\/j.pharmthera.2024.108683_bb0315","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/mds.27115","article-title":"Past, present, and future of Parkinson\u2019s disease: A special essay on the 200th anniversary of the shaking palsy","volume":"32","author":"Obeso","year":"2017","journal-title":"Movement Disorders"},{"issue":"28","key":"10.1016\/j.pharmthera.2024.108683_bb0320","doi-asserted-by":"crossref","first-page":"6761","DOI":"10.1523\/JNEUROSCI.2946-16.2017","article-title":"Lower affinity of Isradipine for L-type Ca2+ channels during substantia Nigra dopamine neuron-like activity: Implications for neuroprotection in Parkinson\u2019s disease","volume":"37","author":"Ortner","year":"2017","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2024.108683_bb0325","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fncom.2013.00013","article-title":"The energy cost of action potential propagation in dopamine neurons: Clues to susceptibility in Parkinson\u2019s disease","volume":"7","author":"Pissadaki","year":"2013","journal-title":"Frontiers in Computational Neuroscience"},{"key":"10.1016\/j.pharmthera.2024.108683_bb0330","doi-asserted-by":"crossref","DOI":"10.1177\/1073858418807887","article-title":"Thinking outside the box (and arrow): Current themes in striatal dysfunction in movement disorders","volume":"25","author":"Plotkin","year":"2019","journal-title":"Neuroscientist"},{"issue":"11","key":"10.1016\/j.pharmthera.2024.108683_bb0335","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s41583-020-0360-9","article-title":"Locus coeruleus: A new look at the blue spot","volume":"21","author":"Poe","year":"2020","journal-title":"Nature Reviews. Neuroscience"},{"issue":"5321","key":"10.1016\/j.pharmthera.2024.108683_bb0340","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science (New York, N.Y.)"},{"issue":"5","key":"10.1016\/j.pharmthera.2024.108683_bb0345","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/mds.27670","article-title":"Prodromal Parkinson\u2019s disease: The decade past, the decade to come","volume":"34","author":"Postuma","year":"2019","journal-title":"Movement Disorders"},{"issue":"12","key":"10.1016\/j.pharmthera.2024.108683_bb0350","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Movement Disorders"},{"issue":"49","key":"10.1016\/j.pharmthera.2024.108683_bb0355","doi-asserted-by":"crossref","first-page":"15414","DOI":"10.1523\/JNEUROSCI.4742-09.2009","article-title":"Cav1.3 channel voltage dependence, not Ca2+ selectivity, drives pacemaker activity and amplifies bursts in Nigral dopamine neurons","volume":"29","author":"Putzier","year":"2009","journal-title":"Journal of Neuroscience"},{"issue":"3","key":"10.1016\/j.pharmthera.2024.108683_bb0360","doi-asserted-by":"crossref","DOI":"10.1002\/ana.24066","article-title":"Lewy body extracts from Parkinson disease brains trigger \u03b1-synuclein pathology and neurodegeneration in mice and monkeys","volume":"75","author":"Recasens","year":"2014","journal-title":"Annals of Neurology"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108683_bb0365","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00401-017-1792-9","article-title":"Spread of aggregates after olfactory bulb injection of \u03b1-synuclein fibrils is associated with early neuronal loss and is reduced long term","volume":"135","author":"Rey","year":"2018","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.pharmthera.2024.108683_bb0370","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/ana.21937","article-title":"L-type Calcium Channel blockers and Parkinson disease in Denmark","volume":"67","author":"Ritz","year":"2010","journal-title":"Annals of Neurology"},{"issue":"6","key":"10.1016\/j.pharmthera.2024.108683_bb0375","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/nn.3717","article-title":"Mitochondrial oxidant stress in locus coeruleus is regulated by activity and nitric oxide synthase","volume":"17","author":"Sanchez-Padilla","year":"2014","journal-title":"Nature Neuroscience"},{"issue":"23","key":"10.1016\/j.pharmthera.2024.108683_bb0380","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1126\/sciadv.abm4560","article-title":"Cav1.3 calcium channels are full-range linear amplifiers of firing frequencies in lateral DA SN neurons","volume":"8","author":"Shin","year":"2022","journal-title":"Science Advances"},{"key":"10.1016\/j.pharmthera.2024.108683_bb0385","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.67464","article-title":"\u03b22-subunit alternative splicing stabilizes Cav2.3 Ca2+ channel activity during continuous midbrain dopamine neuron-like activity","volume":"11","author":"Siller","year":"2022","journal-title":"ELife"},{"key":"10.1016\/j.pharmthera.2024.108683_bb0390","doi-asserted-by":"crossref","DOI":"10.1126\/science.1090278","article-title":"\u03b1-Synuclein locus triplication causes Parkinson\u2019s disease","author":"Singleton","year":"2003","journal-title":"Science"},{"issue":"6645","key":"10.1016\/j.pharmthera.2024.108683_bb0395","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"issue":"41","key":"10.1016\/j.pharmthera.2024.108683_bb0400","doi-asserted-by":"crossref","first-page":"13586","DOI":"10.1523\/JNEUROSCI.5069-13.2014","article-title":"Mutant alpha-synuclein enhances firing frequencies in dopamine substantia nigra neurons by oxidative impairment of A-type potassium channels","volume":"34","author":"Subramaniam","year":"2014","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2024.108683_bb0405","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/mds.25187","article-title":"Neuronal vulnerability, pathogenesis, and Parkinson\u2019s disease","volume":"28","author":"Sulzer","year":"2013","journal-title":"Movement Disorders"},{"issue":"2","key":"10.1016\/j.pharmthera.2024.108683_bb0410","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/mds.28850","article-title":"Re-analysis of the STEADY-PD II trial-evidence for slowing the progression of Parkinson\u2019s disease","volume":"37","author":"Surmeier","year":"2022","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"2","key":"10.1016\/j.pharmthera.2024.108683_bb0415","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrn.2016.178","article-title":"Selective neuronal vulnerability in Parkinson disease","volume":"18","author":"Surmeier","year":"2017","journal-title":"Nature Reviews Neuroscience"},{"issue":"15","key":"10.1016\/j.pharmthera.2024.108683_bb0420","doi-asserted-by":"crossref","first-page":"10736","DOI":"10.1074\/jbc.R112.410530","article-title":"Calcium, bioenergetics, and neuronal vulnerability in Parkinson\u2019s disease","volume":"288","author":"Surmeier","year":"2013","journal-title":"Journal of Biological Chemistry"},{"issue":"Figure 1","key":"10.1016\/j.pharmthera.2024.108683_bb0425","first-page":"1","article-title":"Calcium, bioenergetics, and Parkinson\u2019 s disease","volume":"9","author":"Surmeier","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108683_bb0435","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awz380","article-title":"\u03b1-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: A prodromal Parkinson\u2019s disease model","volume":"143","author":"Taguchi","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2024.108683_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroscience.2019.06.005","article-title":"\u03b1-Synuclein 2.0 \u2014 Moving towards cell type specific pathophysiology","volume":"412","author":"Thakur","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2024.108683_bb0445","doi-asserted-by":"crossref","DOI":"10.1038\/s41575-020-0339-z","article-title":"Parkinson disease and the gut: New insights into pathogenesis and clinical relevance","author":"Travagli","year":"2020","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"key":"10.1016\/j.pharmthera.2024.108683_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117412","article-title":"Calcium Channel blockers are associated with reduced risk of Parkinson\u2019s disease in patients with hypertension: A population-based retrospective cohort study","volume":"424","author":"Tseng","year":"2021","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.pharmthera.2024.108683_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106328","article-title":"Feed-forward metabotropic signaling by Cav1 Ca2+ channels supports pacemaking in pedunculopontine cholinergic neurons","volume":"188","author":"Tubert","year":"2023","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2024.108683_bb0460","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nbd.2018.08.017","article-title":"The pedunclopontine nucleus and Parkinson\u2019s disease","volume":"128","author":"Tubert","year":"2019","journal-title":"Neurobiology of Disease"},{"issue":"9","key":"10.1016\/j.pharmthera.2024.108683_bb0465","doi-asserted-by":"crossref","DOI":"10.1002\/mds.28512","article-title":"\u03b1-Synuclein spread from olfactory bulb causes Hyposmia, anxiety, and memory loss in BAC-SNCA mice","volume":"36","author":"Uemura","year":"2021","journal-title":"Movement Disorders"},{"issue":"13","key":"10.1016\/j.pharmthera.2024.108683_bb0470","article-title":"Neuron-to-neuron \u03b1-synuclein propagation in vivo is independent of neuronal injury","volume":"3","author":"Ulusoy","year":"2015","journal-title":"Acta Neuropathologica Communications"},{"issue":"7","key":"10.1016\/j.pharmthera.2024.108683_bb0475","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/emmm.201302475","article-title":"Caudo-rostral brain spreading of \u03b1-synuclein through vagal connections","volume":"5","author":"Ulusoy","year":"2013","journal-title":"EMBO Molecular Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2024.108683_bb0480","first-page":"1","article-title":"The prion hypothesis in Parkinson\u2019s disease: Braak to the future","volume":"2","author":"Visanji","year":"2014","journal-title":"Acta Neuropathologica Communications"},{"issue":"11","key":"10.1016\/j.pharmthera.2024.108683_bb0485","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41583-020-0367-2","article-title":"Psychedelic drugs: Neurobiology and potential for treatment of psychiatric disorders","volume":"21","author":"Vollenweider","year":"2020","journal-title":"Nature Reviews Neuroscience"},{"issue":"8","key":"10.1016\/j.pharmthera.2024.108683_bb0490","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S1474-4422(19)30140-1","article-title":"Serotonergic pathology and disease burden in the premotor and motor phase of A53T \u03b1-synuclein parkinsonism: A cross-sectional study","volume":"18","author":"Wilson","year":"2019","journal-title":"The Lancet Neurology"},{"issue":"39","key":"10.1016\/j.pharmthera.2024.108683_bb0495","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abp8701","article-title":"Ca2+ channels couple spiking to mitochondrial metabolism in substantia nigra dopaminergic neurons","volume":"8","author":"Zampese","year":"2022","journal-title":"Science Advances"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725824001037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725824001037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T22:28:06Z","timestamp":1721082486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725824001037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":98,"alternative-id":["S0163725824001037"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2024.108683","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ion channel dysregulation and cellular adaptations to alpha-synuclein in stressful pacemakers of the parkinsonian brainstem","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2024.108683","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108683"}}